TRPV1 and obesity disorder: However, while our findings establish CAP as a TRPV1-dependent hepatoprotective agent in diet-induced obesity, it remains unclear whether these effects are mediated solely through systemic metabolic improvements or whether CAP also acts directly on the liver, independent of weight reduction.